Catalyst Wire Dossier Catalyst Wire Dossier

Xlucane

null · Xbrane Biopharma AB
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Xlucane, covering 2023-11-13 to 2023-11-13. Get the full timeline:

Most recent: Clinical Trial Update: Comparing the Efficacy and Safety of Biosimilar Candidate Xlucane Versus Lucentis® in Patients With nAMD [Phase 3]

See pricing